Hasil Pencarian - Shivaprasada Gadag

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 1; peer review: 2 approved]

    Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro s... oleh Shama Prasada Kabekkodu, Usha Nayak, Aditi Chopra, Richard Lobo, Ananth Srivatsa, Divya Adiga, Amee Sanghavi, Ashmeet Shah, Shivaprasada Gadag, Karthik Sivaraman

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]

    Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro s... oleh Shama Prasada Kabekkodu, Usha Nayak, Aditi Chopra, Richard Lobo, Ananth Srivatsa, Divya Adiga, Amee Sanghavi, Ashmeet Shah, Shivaprasada Gadag, Karthik Sivaraman

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 3; peer review: 2 approved]

    Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro s... oleh Shama Prasada Kabekkodu, Usha Nayak, Aditi Chopra, Richard Lobo, Ananth Srivatsa, Divya Adiga, Amee Sanghavi, Ashmeet Shah, Shivaprasada Gadag, Karthik Sivaraman

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: